FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely cardiology, and can be used to predict adverse cardiovascular events within a year after a myocardial infarction on the basis of molecular genetic analysis. The method includes the determination of the following factors: the age of the patient at the time of myocardial infarction (MI), the presence in the genotype of the dominant allele D of I/D polymorphism of the ACE gene, the presence of a multivessel lesion of the coronary arteries (CA) involving the anterior descending artery (ADA) according to the results of coronary angiography (CAG) at the time of index MI, as well as the presence of coronary heart disease (CHD) in combination with arterial hypertension (AH) diagnosed before the development of index MI. The probability of the development of adverse cardiovascular events during the year after one suffered is calculated according to the following formula: p1/(1+EXP(-z)), where p is the probability of the development of adverse cardiovascular events; z is the value of the discriminant function. If the p value is equal to or more than 0.5, the development of adverse cardiovascular events is predicted within a year after suffering MI.
EFFECT: use of the invention makes it possible to determine with high accuracy the probability of the development of adverse cardiovascular events within a year after the previous MI, which contributes to the allocation of a priority cohort of patients with increased risk for subsequent more intensive dispensary monitoring and the organization of the most personalized measures aimed at preventing the development of adverse cardiovascular events in them in the post-infarction period.
1 cl, 3 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF UNFAVORABLE CARDIOVASCULAR EVENTS WITHIN A YEAR AFTER CORONARY ARTERY BYPASS SURGERY | 2020 |
|
RU2731305C1 |
METHOD OF PREDICTING THE DEVELOPMENT OF LEFT VENTRICULAR ANEURYSM IN PATIENTS AFTER MYOCARDIAL INFARCTION, TAKING INTO ACCOUNT GENETIC FACTORS | 2022 |
|
RU2801684C1 |
METHOD FOR PREDICTING LONG-TERM ADVERSE OUTCOMES OF MYOCARDIAL INFARCTION COMPLICATED BY SYSTOLIC DYSFUNCTION IN PATIENTS WITH CEREBRAL ATHEROSCLEROSIS | 2021 |
|
RU2762976C1 |
METHOD FOR PREDICTING THE RISK OF DEATH OR NONFATAL MYOCARDIAL INFARCTION IN PATIENTS IN THE NEXT SIX YEARS AFTER NON-ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME | 2018 |
|
RU2681500C1 |
METHOD OF GENETIC DIAGNOSTICS OF UNFAVOURABLE OUTCOME IN PATIENTS WITHIN ONE YEAR AFTER ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION | 2012 |
|
RU2502474C1 |
METHOD FOR PREDICTION OF UNFAVOURABLE CARDIOVASCULAR EVENTS IN ELDERLY AND SENILE PATIENTS WITHIN FIVE YEARS AFTER SUFFERED MYOCARDIAL INFARCTION | 2018 |
|
RU2691617C1 |
METHOD FOR PREDICTION OF UNFAVORABLE COURSE OF POST-MI FOR PATIENTS OF WORKING AGE | 2016 |
|
RU2613441C1 |
METHOD FOR PREDICTION OF UNFAVOURABLE CARDIOVASCULAR EVENTS FIVE YEARS AFTER SUFFERING MYOCARDIAL INFARCTION TAKING INTO ACCOUNT ADHERENCE OF PATIENTS TO TREATMENT | 2015 |
|
RU2599372C1 |
METHOD FOR DETERMINING THE RISK OF MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION USING GENETIC MARKERS | 2019 |
|
RU2711623C1 |
METHOD OF PREDICTING CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2017 |
|
RU2670689C9 |
Authors
Dates
2022-03-17—Published
2021-03-30—Filed